Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NTCP S267F variant associates with decreased susceptibility to HBV and HDV infection and decelerated progression of related liver diseases
Mai Thanh Binh, Nghiem Xuan Hoan, Hoang Văn Tong, et al.
International Journal of Infectious Diseases (2019) Vol. 80, pp. 147-152
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Bile formation and secretion: An update
James L. Boyer, Carol J. Soroka
Journal of Hepatology (2021) Vol. 75, Iss. 1, pp. 190-201
Closed Access | Times Cited: 78
Structure of antiviral drug bulevirtide bound to hepatitis B and D virus receptor protein NTCP
H Liu, Dariusz Zakrzewicz, Kamil Nosol, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 16
Roles of Farnesyl-Diphosphate Farnesyltransferase 1 in Tumour and Tumour Microenvironments
Nguyễn Thị Thu Hà, Chang Hoon Lee
Cells (2020) Vol. 9, Iss. 11, pp. 2352-2352
Open Access | Times Cited: 47
Efficacy and Safety of Bulevirtide plus Tenofovir Disoproxil Fumarate in Real-World Patients with Chronic Hepatitis B and D Co-Infection
Toni Herta, Magdalena Hahn, Melanie Maier, et al.
Pathogens (2022) Vol. 11, Iss. 5, pp. 517-517
Open Access | Times Cited: 28
Molecular regulation of the hepatic bile acid uptake transporter and HBV entry receptor NTCP
Monique D. Appelman, Jochen M. Wettengel, Ulrike Protzer, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2021) Vol. 1866, Iss. 8, pp. 158960-158960
Open Access | Times Cited: 29
Mechanistic insights into the inhibition of NTCP by myrcludex B
Joanne M. Donkers, Monique D. Appelman, Stan F.J. van de Graaf
JHEP Reports (2019) Vol. 1, Iss. 4, pp. 278-285
Open Access | Times Cited: 34
Multitasking Na+/Taurocholate Cotransporting Polypeptide (NTCP) as a Drug Target for HBV Infection: From Protein Engineering to Drug Discovery
Dariusz Zakrzewicz, Joachim Geyer
Biomedicines (2022) Vol. 10, Iss. 1, pp. 196-196
Open Access | Times Cited: 17
Interactions of Na+/taurocholate cotransporting polypeptide with host cellular proteins upon hepatitis B and D virus infection: novel potential targets for antiviral therapy
Dariusz Zakrzewicz, Joachim Geyer
Biological Chemistry (2023) Vol. 404, Iss. 7, pp. 673-690
Open Access | Times Cited: 8
The loss of hepatitis B virus receptor NTCP/SLC10A1 in human liver cancer cells is due to epigenetic silencing
Marwa K. Ibrahim, Cheng‐Der Liu, Liyong Zhang, et al.
Journal of Virology (2024)
Closed Access | Times Cited: 3
The Culprit Behind HBV-Infected Hepatocytes: NTCP
Shenghao Li, Liyuan Hao, Jiali Deng, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 4839-4858
Open Access | Times Cited: 3
Hepatitis B virus genotypes in precision medicine of hepatitis B-related hepatocellular carcinoma: Where we are now
Caecilia Sukowati, Sri Jayanti, Turyadi Turyadi, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 4, pp. 1097-1103
Open Access | Times Cited: 2
Role of Biomarkers in Guiding Cure of Viral Hepatitis B
Marı́a Buti, Mar Riveiro‐Barciela, Francisco Rodríguez‐Frías, et al.
Seminars in Liver Disease (2019) Vol. 40, Iss. 01, pp. 049-060
Closed Access | Times Cited: 18
Role of sodium taurocholate cotransporting polypeptide (NTCP) in HBV-induced hepatitis: Opportunities for developing novel therapeutics
Zhentao Zhang, Qi Zhang, Yiwen Zhang, et al.
Biochemical Pharmacology (2023) Vol. 219, pp. 115956-115956
Closed Access | Times Cited: 6
Long-term trans-inhibition of the hepatitis B and D virus receptor NTCP by taurolithocholic acid
Kira A. A. T. Lowjaga, Michael Kirstgen, Simon Müller, et al.
AJP Gastrointestinal and Liver Physiology (2020) Vol. 320, Iss. 1, pp. G66-G80
Open Access | Times Cited: 15
Genetically edited hepatic cells expressing the NTCP-S267F variant are resistant to hepatitis B virus infection
Takuro Uchida, Seung Bum Park, Tadashi Inuzuka, et al.
Molecular Therapy — Methods & Clinical Development (2021) Vol. 23, pp. 597-605
Open Access | Times Cited: 13
Hepatic Expression of the Na+-Taurocholate Cotransporting Polypeptide Is Independent from Genetic Variation
Roman Tremmel, Anne T. Nies, Barbara A. C. van Eijck, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7468-7468
Open Access | Times Cited: 9
Tyrosine 146 of the Human Na+/Taurocholate Cotransporting Polypeptide (NTCP) Is Essential for Its Hepatitis B Virus (HBV) Receptor Function and HBV Entry into Hepatocytes
Dariusz Zakrzewicz, Regina Leidolf, Sebastian N. Kunz, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1259-1259
Open Access | Times Cited: 8
Oligomerization of the HBV/HDV functional receptor NTCP expressed in Sf9 insect cell
Tan Qin, Yu Wang, Jing Nie, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2022) Vol. 1866, Iss. 11, pp. 130224-130224
Closed Access | Times Cited: 7
The Clinical Relevance and Immune Correlation of SLC10 Family Genes in Liver Cancer
Shan Tian, Jiao Li, Jiankang Xiang, et al.
Journal of Hepatocellular Carcinoma (2022) Vol. Volume 9, pp. 1415-1431
Open Access | Times Cited: 7
SLC10A1 rs2296651 variant (S267F mutation) predicts biochemical traits, hepatitis B virus infection susceptibility and the risk of gallstone disease
Yu‐Lin Ko, Wei-Lun Tuan, Ming-Sheng Teng, et al.
Molecular Genetics and Genomics (2024) Vol. 299, Iss. 1
Closed Access | Times Cited: 1
The characteristic of the synonymous codon usage and phylogenetic analysis of hepatitis B virus
Xiaoming Qi, Chaojun Wei, Yonghong Li, et al.
Genes & Genomics (2020) Vol. 42, Iss. 7, pp. 805-815
Open Access | Times Cited: 7
Chronic hepatitis B virus infection and fibrosis: novel non-invasive approaches for diagnosis and risk stratification
Francesco Stalla, Angelo Armandi, Chiara Marinoni, et al.
Minerva Gastroenterology (2021) Vol. 68, Iss. 3
Closed Access | Times Cited: 6
NTCP polymorphisms were associated with fibrosis development in patients with chronic HBV infection
Zhenzhen Su, Bei Cai, Xiaojuan Wu, et al.
The Journal of Infection in Developing Countries (2022) Vol. 16, Iss. 01, pp. 179-186
Open Access | Times Cited: 4
The NTCP p.Ser267Phe Variant Is Associated With a Faster Anti-HBV Effect on First-Line Nucleos(t)ide Analog Treatment
Lina Wu, Wenxiong Xu, Xuejun Li, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 5
NTCP gene polymorphisms and hepatitis B virus infection status in a Ghanaian population
E Nyarko, Christian Obirikorang, William K. B. A. Owiredu, et al.
Virology Journal (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top